U.S. federal trademark · Serial No. 98739864 · Reg. No. 8471555
Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in pen injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in pen injectors for treatment of Polycythemia vera; Pharmaceutical preparations contained in pen injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors for treatment of Polycythemia vera; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.